Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, reached its maximum allowed daily gain of 5.0%, closing at Rs 1,947.10 after touching an intraday low of Rs 1,800. The 5% price band capped the rally, effectively freezing trading at the ceiling price. This scenario indicates unfilled demand, as buyers were willing to purchase more shares but no sellers were prepared to sell at or below this level. The total traded volume was 55,931 shares, with a turnover of approximately Rs 10.6 crore. The circuit lock prevented further price appreciation despite persistent buying interest — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Interestingly, delivery volumes on 24 Jun 2026 fell sharply by 53.64% compared to the 5-day average, with only 3,980 shares taken in delivery. This decline suggests that the recent upper circuit move may have been driven more by speculative buying rather than long-term accumulation. Volume on a circuit day is mechanically suppressed due to the price lock, but the falling delivery volume raises questions about the sustainability of the buying pressure. The weighted average price indicates that more volume traded closer to the day's low, hinting at some intraday profit-taking or cautious participation despite the overall upward move — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages: 5-day, 20-day, 50-day, 100-day, and 200-day. This alignment confirms a bullish trend and suggests that the upper circuit move is consistent with an ongoing positive momentum. The stock has been gaining for three consecutive days, rising 15.08% over this period, reinforcing the strength of the current uptrend. The circuit event, therefore, appears to be an amplification of an already established bullish pattern rather than an isolated spike.

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately Rs 2,427 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of around Rs 0.26 crore based on 2% of the 5-day average traded value. While this level of liquidity is reasonable for a micro-cap, it still implies limited institutional-grade liquidity and a relatively thin order book. This thinness can exacerbate price moves and circuit hits, as even modest buying or selling interest can cause outsized price swings. The upper circuit lock, therefore, carries a liquidity risk — but with near-zero liquidity and a Rs 2,427 crore market cap, should you be chasing Venus Remedies Ltd?

Intraday Price Action

The intraday range was fairly wide, with the stock touching a low of Rs 1,800 and a high of Rs 1,947.10, the circuit price. The weighted average price skewed towards the lower end of this range, indicating that while the stock closed at the upper circuit, much of the volume was executed at prices below the ceiling. This pattern is typical for circuit hits, where the price is mechanically capped but demand remains unfulfilled. The narrow trading window near the circuit price towards the close suggests that buyers were eager to accumulate shares at the highest permissible price, while sellers remained absent.

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by innovation and regulatory complexity. The company’s recent price action, including the new 52-week and all-time high of Rs 1,947.10, reflects market optimism. However, the sharp delivery volume decline tempers enthusiasm, suggesting that the rally may be more technical than fundamentally driven at this stage.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1,947.10 capped a 5.0% gain for Venus Remedies Ltd, signalling strong buying interest that exceeded the price band’s allowance. However, the sharp fall in delivery volumes on the previous day suggests that the move may be driven more by speculative demand than by long-term accumulation. The stock’s position above all major moving averages confirms a bullish trend, but the micro-cap status and moderate liquidity introduce a risk of price volatility and difficulty in executing large trades. Investors should weigh these factors carefully — after a 5.0% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today